Abstract:Under physiological conditions, adenosine triphosphate (ATP) is present at low levels in the extracellular milieu, being massively released by stressed or dying cells. Once outside the cells, ATP and related nucleotides/nucleoside generated by ectonucleotidases mediate a high evolutionary conserved signaling system: the purinergic signaling, which is involved in a variety of pathological conditions, including inflammatory diseases. Extracellular ATP has been considered an endogenous adjuvant that can initiate inflammation by acting as a danger signal through the activation of purinergic type 2 receptors-P2 receptors (P2Y G-protein coupled receptors and P2X ligand-gated ion channels). Among the P2 receptors, the P2X7 receptor is the most extensively studied from an immunological perspective, being involved in both innate and adaptive immune responses. P2X7 receptor activation induces large-scale ATP release via its intrinsic ability to form a membrane pore or in association with pannexin hemichannels, boosting purinergic signaling. ATP acting via P2X7 receptor is the second signal to the inflammasome activation, inducing both maturation and release of pro-inflammatory cytokines, such as IL-1β and IL-18, and the production of reactive nitrogen and oxygen species. Furthermore, the P2X7 receptor is involved in caspases activation, as well as in apoptosis induction. During adaptive immune response, P2X7 receptor modulates the balance between the generation of T helper type 17 (Th17) and T regulatory (Treg) lymphocytes. Therefore, this receptor is involved in several inflammatory pathological conditions. In infectious diseases and cancer, P2X7 receptor can have different and contrasting effects, being an angel or a demon depending on its level of activation, cell studied, type of pathogen, and severity of infection. In neuroinflammatory and neurodegenerative diseases, P2X7 upregulation and function appears to contribute to disease progression. In this review, we deeply discuss P2X7 receptor dual function and its pharmacological modulation in the context of different pathologies, and we also highlight the P2X7 receptor as a potential target to treat inflammatory related diseases.

The P2X7 Receptor is a Master Regulator of Microparticle and Mitochondria Exchange in Mouse Microglia

Mitochondrial P2X7 Receptor Localization Modulates Energy Metabolism Enhancing Physical Performance

The P2X7 receptor directly interacts with the NLRP3 inflammasome scaffold protein

P2X7 Receptor and Extracellular Vesicle Release

Modulation of Microglial Function by ATP-Gated P2X7 Receptors: Studies in Rat, Mice and Human

Inherent P2X7 Receptors Regulate Macrophage Functions during Inflammatory Diseases

Regulation of Immune Response by P2X7 Receptor.

IL-1RA Disrupts ATP Activation of P2RX7 in Human Monocyte-Derived Microglia-like Cells

The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment

Detection and Functional Evaluation of the P2X7 Receptor in hiPSC Derived Neurons and Microglia-Like Cells

Differential regulation of microglial P2X4 and P2X7 ATP receptors following LPS-induced activation

Astrocytic and Oligodendrocytic P2X7 Receptors Determine Neuronal Functions in the CNS

P2X7 receptor activation leads to NLRP3-independent IL-1β release by human macrophages

P2X Receptor-Dependent Modulation of Mast Cell and Glial Cell Activities in Neuroinflammation

The P2X7 receptor in mucosal adaptive immunity

Macrophage activation and polarization modify P2X7 receptor secretome influencing the inflammatory process

The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?

Silencing of the P2X(7) Receptor Enhances Amyloid-Β Phagocytosis by Microglia.

Techniques for evaluating the ATP-gated ion channel P2X7 receptor function in macrophages and microglial cells

P2 Receptors: Novel Disease Markers and Metabolic Checkpoints in Immune Cells

Exploring P2X receptor activity: A journey from cellular impact to electrophysiological profiling